Olli Yli-Harja

Keyphrases

1. Glioblastoma 100%
2. Prostate Cancer 89%
3. Apoptosis 80%
4. GPR17 79%
5. Alkylaminophenol 62%
6. Cell Death 51%
7. P2Y Receptors 49%
8. G Protein-coupled Receptor 47%
9. Indoline 45%
10. Cell Cycle Arrest 44%
11. Methyl 42%
12. Caspase-3 41%
13. Cytotoxicity 41%
14. Signaling Activation 40%
15. Escherichia Coli 39%
16. Glioblastoma multiforme 38%
17. Breast Cancer 38%
18. Anticancer Activity 37%
19. Reactive Oxygen Species 37%
20. Cell Growth 37%
21. Signaling Pathway 37%
22. Library of Integrated Network-based Cellular Signatures 35%
23. Nitrophenyl 35%
24. Induced Cell Death 34%
25. IC50 34%
26. Temozolomide 32%
27. Methylphenols 32%
28. Explainability 29%
29. Pharmacogenomics 29%
30. P2Y1 28%
31. LN229 27%
32. Phenol Derivatives 27%
33. Network Structure 27%
34. Glioblastoma Therapy 27%
35. Molecular Interactions 27%
36. Breast Cancer Cells 26%
37. Indole Derivatives 26%
38. Prognostic Biomarker 26%
39. In Cancer 25%
40. Glioblastoma Cells 25%
41. Lac Promoter 24%
42. Big Data 24%
43. Machine Learning 24%
44. Anti-glioblastoma 24%
45. Computational Analysis 23%
46. In Vitro Characterization 23%
47. Cancer Cell Death 23%
48. Fibroblast Growth Factor Receptor 3 (FGFR3) 23%
49. Preclinical Validation 23%
50. Structural Properties 23%